http://www.WhitneyVandell.com Whitney
Vandell’s debut record takes its namesake from that same title, one
that has been hard-earned by Vandell over years of intense work. The
African-native instrumentalist has released one of the more intriguing
and eclectic instrumental records thus far this year on the indie
scene. What makes the ‘One-Girl Symphony’ so interesting is Vandell’s
hand over a vast array of genres. The record style-hops with ridiculous
tact, shifting from classical influences to rock and roll and blues in
seamless movements. Speaking of which, there actually are movements.
Her debut album is broken into four autobiographical sections of three
songs each: Teenage Turbulence, The Formative Years, Return to
Innocence & Hope, and Empty Promises to Broken Hearts.
For the past six years Brookdale, the nation’s largest senior living provider, has fulfilled its residents’ life-long dreams and Wishes by partnering with Wish of a Lifetime™, an organization dedicated to shifting the way society views and values our oldest generation. During this time, some of the most exciting Wishes have taken place in the skies above. Since the partnership began, more than 70 aerial themed Wishes have been granted to Brookdale residents who had dreams of skydiving, taking helicopter tours, flying fighter jets and more.
“Seeing our residents fulfill their Wish of a Lifetime through these incredible aviation adventures shows how older adults continue to act on their dreams and passions,” says Sara Terry, vice president of resident and family engagement. “We are always thrilled to find opportunities for our residents to enrich their lives and honor their spirit.”
To view the multimedia release go to:
http://www.multivu.com/players/English/77221510-brookdale-senior-wish-of-a-lifetime/
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
Three Olives®, the original premium flavored vodka brand made with vodka imported from England, introduces “Find Otherness,” a new campaign celebrating those who believe a playful spirit of eccentricity makes life more exciting. “Find Otherness” launches today across video, native and social platforms with a 30-second spot and five vignettes highlighting the stories of individuals who embrace new perspectives and cast boring to the wind. The campaign will continue throughout the year with new partnerships, events and product offerings.
Three Olives collaborated with the duo behind Van Orton Design, whose signature kaleidoscopic, neon-colored aesthetic brings “Find Otherness” to life in the perspective-shifting new creative. The duo is featured in the first vignette, entitled “Find Inspiration,” and can be viewed at www.threeolives.com. The Van Orton brothers never reveal their faces in public, so the two-minute video is filmed from their perspective, singularly capturing what they see that brings inspiration to their art.
To view the multimedia release go to:
http://www.multivu.com/players/English/8073751-three-olives-vodka-find-otherness/
As asset growth in traditional hedge funds from institutional investors continues to slow, hedge fund managers are pinning their hopes on the power of new products to attract investor assets and drive growth. However, many are underestimating the costs involved and the effect on margins, according to EY’s 2014 global hedge fund and investor survey: Shifting strategies: winning investor assets in a competitive landscape.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7365751-ey-survey-institutional-investors-shifting-allocation-strategies-driving-hedge-funds-towards-new-products/
